Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Current Opinion in Drug Discovery & Development|September 19, 2001
Protein models in drug discoveryM Norin, M SundströmLipids|August 1, 1993
The role of arginines in stabilizing the active open-lid conformation of Rhizomucor miehei lipaseM Holmquist, M Norin, K HultBiophysical Journal|August 1, 1994
Molecular dynamics simulations of an enzyme surrounded by vacuum, water, or a hydrophobic solventM Norin, F Haeffner, K Hult, et al.Protein Engineering|April 9, 1999
Hydrophobicity engineering of cholera toxin A1 subunit in the strong adjuvant fusion protein CTA1-DDL Agren, M Norin, N Lycke, et al.Virus Research|June 15, 2000
Fine characterization of a V3-region neutralizing epitope in human immunodeficiency virus type 2A Mörner, A Achour, M Norin, et al.Viral Immunology|May 20, 1999
Characterization of neutralizing sites in the second variable and fourth variable region in gp125 and a conserved region in gp36 of human immunodeficiency virus type 2P Skott, A Achour, M Norin, et al.Protein Engineering|November 1, 1993
Theoretical studies of Rhizomucor miehei lipase activationM Norin, O Olsen, A Svendsen, et al.Protein Science : a Publication of the Protein Society|September 1, 1994
Computer modeling of substrate binding to lipases from Rhizomucor miehei, Humicola lanuginosa, and Candida rugosaM Norin, F Haeffner, A Achour, et al.The Journal of Biological Chemistry|May 9, 1997
Identification of framework residues in a secreted recombinant antibody fragment that control production level and localization in Escherichia coliG Forsberg, M Forsgren, M Jaki, et al.Biochemistry|December 26, 1995
Crystallographic and molecular-modeling studies of lipase B from Candida antarctica reveal a stereospecificity pocket for secondary alcoholsJ Uppenberg, N Ohrner, M Norin, et al.Pageof 1